184 related articles for article (PubMed ID: 37216686)
21. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
[TBL] [Abstract][Full Text] [Related]
22. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ
J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220
[TBL] [Abstract][Full Text] [Related]
23. The role of the RAS pathway in iAMP21-ALL.
Ryan SL; Matheson E; Grossmann V; Sinclair P; Bashton M; Schwab C; Towers W; Partington M; Elliott A; Minto L; Richardson S; Rahman T; Keavney B; Skinner R; Bown N; Haferlach T; Vandenberghe P; Haferlach C; Santibanez-Koref M; Moorman AV; Kohlmann A; Irving JA; Harrison CJ
Leukemia; 2016 Sep; 30(9):1824-31. PubMed ID: 27168466
[TBL] [Abstract][Full Text] [Related]
24. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
[TBL] [Abstract][Full Text] [Related]
26. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle.
Robinson HM; Harrison CJ; Moorman AV; Chudoba I; Strefford JC
Genes Chromosomes Cancer; 2007 Apr; 46(4):318-26. PubMed ID: 17243167
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia.
Duployez N; Boudry-Labis E; Decool G; Grzych G; Grardel N; Abou Chahla W; Preudhomme C; Roche-Lestienne C
Clin Case Rep; 2015 Oct; 3(10):814-6. PubMed ID: 26509013
[TBL] [Abstract][Full Text] [Related]
28. Intrachromosomal amplification of chromosome 21 (iAMP21) detected by ETV6/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case report.
Garcia DR; Arancibia AM; Ribeiro RC; Land MG; Silva ML
Rev Bras Hematol Hemoter; 2013; 35(5):369-71. PubMed ID: 24255623
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
30. Targeting signaling pathways in acute lymphoblastic leukemia: new insights.
Harrison CJ
Hematology Am Soc Hematol Educ Program; 2013; 2013():118-25. PubMed ID: 24319172
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
[TBL] [Abstract][Full Text] [Related]
32. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.
Kiss R; Gángó A; Benard-Slagter A; Egyed B; Haltrich I; Hegyi L; de Groot K; Király PA; Krizsán S; Kajtár B; Pikó H; Pajor L; Vojcek Á; Matolcsy A; Kovács G; Szuhai K; Savola S; Bödör C; Alpár D
Mod Pathol; 2020 May; 33(5):812-824. PubMed ID: 31857684
[TBL] [Abstract][Full Text] [Related]
34. Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.
Trinquand A; Betts DR; Harte S; Sills A; Rooney S; Barrett N; Storey L; Malone A; O'Marcaigh A; Smith OP
Leuk Lymphoma; 2024 Feb; 65(2):279-282. PubMed ID: 37909291
[No Abstract] [Full Text] [Related]
35. Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks.
Bungaro S; Dell'Orto MC; Zangrando A; Basso D; Gorletta T; Lo Nigro L; Leszl A; Young BD; Basso G; Bicciato S; Biondi A; te Kronnie G; Cazzaniga G
Genes Chromosomes Cancer; 2009 Jan; 48(1):22-38. PubMed ID: 18803328
[TBL] [Abstract][Full Text] [Related]
36. Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution.
Yang M; Yi ES; Kim HJ; Yoo KH; Koo HH; Kim SH
Blood Res; 2017 Jun; 52(2):100-105. PubMed ID: 28698845
[TBL] [Abstract][Full Text] [Related]
37. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
[TBL] [Abstract][Full Text] [Related]
38. The genomic landscape of pediatric acute lymphoblastic leukemia.
Brady SW; Roberts KG; Gu Z; Shi L; Pounds S; Pei D; Cheng C; Dai Y; Devidas M; Qu C; Hill AN; Payne-Turner D; Ma X; Iacobucci I; Baviskar P; Wei L; Arunachalam S; Hagiwara K; Liu Y; Flasch DA; Liu Y; Parker M; Chen X; Elsayed AH; Pathak O; Li Y; Fan Y; Michael JR; Rusch M; Wilkinson MR; Foy S; Hedges DJ; Newman S; Zhou X; Wang J; Reilly C; Sioson E; Rice SV; Pastor Loyola V; Wu G; Rampersaud E; Reshmi SC; Gastier-Foster J; Guidry Auvil JM; Gesuwan P; Smith MA; Winick N; Carroll AJ; Heerema NA; Harvey RC; Willman CL; Larsen E; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Winter SS; Burke MJ; Salzer W; Dunsmore KP; Angiolillo AL; Crews KR; Downing JR; Jeha S; Pui CH; Evans WE; Yang JJ; Relling MV; Gerhard DS; Loh ML; Hunger SP; Zhang J; Mullighan CG
Nat Genet; 2022 Sep; 54(9):1376-1389. PubMed ID: 36050548
[TBL] [Abstract][Full Text] [Related]
39. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
Moorman AV; Ensor HM; Richards SM; Chilton L; Schwab C; Kinsey SE; Vora A; Mitchell CD; Harrison CJ
Lancet Oncol; 2010 May; 11(5):429-38. PubMed ID: 20409752
[TBL] [Abstract][Full Text] [Related]
40. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
Nguyen D; Li Y; Safah H; Brown TC
Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
